Afya Limited (NASDAQ:AFYA - Get Free Report)'s stock price hit a new 52-week low on Friday . The company traded as low as $14.43 and last traded at $14.54, with a volume of 18836 shares changing hands. The stock had previously closed at $14.63.
Analyst Ratings Changes
AFYA has been the subject of a number of research reports. Wall Street Zen upgraded Afya from a "hold" rating to a "buy" rating in a research report on Saturday, June 14th. UBS Group reiterated a "neutral" rating and issued a $19.50 price objective (up from $17.50) on shares of Afya in a research report on Thursday, June 12th. Three analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $17.60.
Check Out Our Latest Research Report on Afya
Afya Stock Performance
The company has a quick ratio of 1.42, a current ratio of 1.42 and a debt-to-equity ratio of 0.41. The stock has a market cap of $1.37 billion, a P/E ratio of 11.00, a PEG ratio of 0.53 and a beta of 0.58. The stock has a fifty day simple moving average of $17.38 and a 200-day simple moving average of $17.35.
Hedge Funds Weigh In On Afya
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AFYA. Doma Perpetual Capital Management LLC lifted its holdings in shares of Afya by 4.4% during the 1st quarter. Doma Perpetual Capital Management LLC now owns 592,220 shares of the company's stock valued at $10,619,000 after purchasing an additional 25,111 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Afya by 14.0% during the 4th quarter. Renaissance Technologies LLC now owns 412,000 shares of the company's stock valued at $6,543,000 after purchasing an additional 50,700 shares in the last quarter. Perpetual Ltd lifted its holdings in shares of Afya by 1.8% during the 2nd quarter. Perpetual Ltd now owns 151,180 shares of the company's stock valued at $2,700,000 after purchasing an additional 2,730 shares in the last quarter. Lazard Asset Management LLC lifted its holdings in shares of Afya by 54.3% during the 4th quarter. Lazard Asset Management LLC now owns 97,313 shares of the company's stock valued at $1,545,000 after purchasing an additional 34,246 shares in the last quarter. Finally, D. E. Shaw & Co. Inc. lifted its holdings in shares of Afya by 32.9% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 82,817 shares of the company's stock valued at $1,315,000 after purchasing an additional 20,498 shares in the last quarter. Institutional investors own 88.02% of the company's stock.
Afya Company Profile
(
Get Free Report)
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Afya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.
While Afya currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.